Ultrasound unlocks blood-brain barrier in cancer clinical trialnews2021-09-14T12:53:20+00:00September 14th, 2021|Fierce Pharma|
After late-stage trial setback, CureVac terminates COVID-19 vaccine contracts with Wacker, Celonicnews2021-09-14T12:36:41+00:00September 14th, 2021|Fierce Pharma|
To lower prices, Senate leaders, FDA chief urge U.S. patent officials to rethink intellectual property on drugsnews2021-09-14T11:56:02+00:00September 14th, 2021|Fierce Pharma|
FDA starts pilot after AstraZeneca, J&J make case for novel drug delivery excipientsnews2021-09-14T10:35:40+00:00September 14th, 2021|Fierce Pharma|
Windgap bags $17M to advance smaller, longer-life autoinjectorsnews2021-09-14T10:32:17+00:00September 14th, 2021|Fierce Pharma|
Cingulate, gunning for pharma majors, seeks $58M to develop extended-release ADHD drugsnews2021-09-14T10:28:49+00:00September 14th, 2021|Fierce Pharma|
Jubilant Cadista recalls combination birth control pills after failed dissolution testnews2021-09-13T17:28:06+00:00September 13th, 2021|Fierce Pharma|
Sinovac, Numolux in talks to build vaccine facility in South Africa: reportnews2021-09-13T16:51:26+00:00September 13th, 2021|Fierce Pharma|
Bayer pharma goes all-in for digital media buying, moving external operations in-housenews2021-09-13T16:10:36+00:00September 13th, 2021|Fierce Pharma|
Eylea maker Regeneron looks to raise eye health awareness with ‘Now Eye See’ campaignnews2021-09-13T15:09:33+00:00September 13th, 2021|Fierce Pharma|
